Thursday, June 14, 2018 9:04:43 PM
I heard that at some point before, they had one nay-sayer in the FDA on their review team who subsequently quit the FDA and went to work for a competitor. In that case, it wouldn't help them to complain due to getting retroactive proof of CofI. In fact, if what I heard is true and it's just a rumor, by no means definite info, making a stink retroactively would only put them at risk of pissing somebody else at the FDA off, so there seems to be nothing at all to gain and lots to risk losing by complaining in that case. FWIW, I also heard that this CofI was one of or maybe the main reason for the enrollment hold, which would help explain why they never wanted to discuss the above situation with the public because the last thing in the world they want is to get into a pissing contest or blame game against the FDA, when they super need cooperation going forward. Anyway, this is just one of many rumors concerning the enrollment hold - zero effect on what game is on now in any case.
And please note that is totally different from what you are discussing where somebody with a very easy to prove CofI gets involved now and tries to block their regulatory progress. Les and Linda are both Washington insiders. If you think for a minute they don't know the basics of how to deal with the FDA and prevent getting screwed like that, then imho it would be foolish for you to own this stock, 'cause dealing with the govt is supposed to be the biggest value those guys bring to the table. (btw I've also heard that Les had enough to do with getting RTT through that he was invited to go watch Trump sign it, but he declined to go because he's a dem. imo he should have gone anyway and then posted photos of himself there for the publicity.)
Recent NWBO News
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM